Aspen Aerogels Inc (NYSE: ASPN) has reported a loss for its first fiscal quarter (ending March 31) of $-0.02 versus a loss $-0.24 for the same period a year ago. Relative to the consensus estimate of $0.05, this was a shortfall of $-0.07. For the latest four quarters through March 31, E.P.S. were $-0.44 versus $-1.87 for the same period a year ago.
Recent Price Action
Aspen Aerogels Inc (NYSE: ASPN) stock declined by -2.8% on 5/1/24. The shares closed at $15.22. Moreover, this decline was accompanied by above average trading volume at 127% of normal. The stock has been exceptionally strong relative to the market over the last nine months but has declined -8.5% during the last week.
Current PriceTarget Research Rating
ASPN is expected to be Value Creation neutral reflecting capital returns that are forecasted to be in line with the cost of capital.
Aspen Aerogels has a current Value Trend Rating of C (High Neutral). This rating combines very contradictory signals from two proprietary PTR measures of a stock’s attractiveness. Aspen Aerogels has a poor Appreciation Score of 19 but a very high Power Rating of 100, and the High Neutral Value Trend Rating results.
Rating Review
In light of this new information we are reviewing our current Overall Rating of C. This review will be completed in the next several days.
Be the first to comment